2024-11-17 13:53:35
iX Biopharma Reports on Outcome of Wafermine End-of-phase 2 Meeting with US FDA
Corporate/ 2023-07-23
iX Biopharma Reports on Outcome of Wafer...

SINGAPORE,Dec. 11,2019-- Specialty pharmaceutical company iX Biopharma Ltd (SGX:42C) ("iX Biopharma" or,"the Company") i...

Biocon Biologics Symposium on '100 Years of Insulin - Delivering on Universal Access & Equitable Care' Resonates Well With Leading  KOLs at IDF Congress 2019
Health/ 2023-07-22
Biocon Biologics Symposium on '100 ...

BENGALURU,India,Dec. 12,2019-- Biocon Biologics,a fully integrated \'pure play\' global biosimilars organisation,brought together Key Opinio...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release